Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

U.S. News

Georgia: AIDS Vaccine 200 Celebrates Its "Vaccine Soldiers"

August 27, 2010

Action Cycling Atlanta on Sunday presented checks totaling $198,200 to the three beneficiaries of its AIDS Vaccine 200 ride, which was held in May. The cycling organization donated $190,000 to the Emory Vaccine Center, $6,200 to Jerusalem House, and $2,000 to Positive Impact. Since its launch in 2003, the ride has raised about $765,000 for EVC. "Your passion for bike riding and for making a difference kind of come together in a wonderful way, and you make a difference for HIV/AIDS," Mark Mulligan, executive director of EVC's Hope Clinic, said during the celebration at Atlanta's Kai Lin Art gallery. "In doing this, you are all vaccine soldiers -- ambassadors -- and we certainly appreciate it." Mulligan also noted that the Hope Clinic continues to seek volunteers for several ongoing trials. For more information, visit www.medicine.emory.edu/id/hopeclinic/.

Back to other news for August 2010

Adapted from:
Project Q Atlanta
08.26.2010; Matt Hennie


  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More News on HIV/AIDS Bike Rides
Advertisement:
Find out how a Walgreens specially trained pharmacist can help you

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement